
There are some changes in Triple
Test reporting
·
Quadruple test :
Inhibin
A has been added as a fourth parameter making Triple a Quadruple test. This
increases the T 21 detection rate from 69 % to 81 % at 5 % FPR (false positive
rate).
·
Combined Screen
(Quadruple in 2nd trimester + NT done in 1st Trimester)
:
If
CRL & NT were done in first trimester & readings are available, same
can be incorporated in calculation for second trimester screen i.e. quadruple
test. This increases the detection rate to 87 % at 5 % FPR.
·
New risk factors
:
In
first trimester screen, nasal bone status is
incorporated; it increases the detection rate up to 95 % at 5 % FPR. Also
Previous T 21 pregnancy if any can be incorporated as additional risk factor.
·
Combined T13/ T 18 risk
:
First trimester
screen now includes T 13/T 18 risk instead of T 18 alone.
·
Sequential screening
protocol :
Till now, NT
measurement and date of sampling had to be almost the same for first trimester
screen. Now the sampling could be done earlier (exact gestational age on the
day of sampling is required). NT measurement can be done later. All data could
still be incorporated to calculate the risk.
Now the data base will be shared
worldwide with peer group using the same equipment & kits. It will thus
become more relevant and detect individual changes if any.
At a
glance :
|
Protocol |
Detection rate
at 5 % FPR |
|
AFP+HCG+FE3
- Triple |
69
% |
|
AFP+HCG+FE3+
Inhibin A - Quadruple |
81
% |
|
Quadruple
+ 1st trimester NT |
87
% |
|
PAPP–
A + FBHCG + NT |
85
to 90 % |
|
PAPP-A+FBHCG+NT+Nasal
bone |
Aprox
95 % |
Toprani Advanced Lab Systems
April,
2010